NextGen Healthcare
Market Cap
US$1.1b
Last Updated
2019/10/17 23:39 UTC
Data Sources
Company Financials +
Executive Summary
NextGen Healthcare, Inc. provides ambulatory-focused healthcare software and services solutions in the United States.
Snowflake
Fundamentals
Excellent balance sheet and fair value.
Similar Companies
Share Price & News
How has NextGen Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
5.3%
NXGN
1.4%
US Healthcare Services
1.8%
US Market
1 Year Return
-17.8%
NXGN
15.6%
US Healthcare Services
7.3%
US Market
Return vs Industry: NXGN underperformed the US Healthcare Services industry which returned 15.6% over the past year.
Return vs Market: NXGN underperformed the US Market which returned 7.3% over the past year.
Shareholder returns
| NXGN | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.3% | 1.4% | 1.8% |
| 30 Day | 0.3% | -0.9% | -0.7% |
| 90 Day | -17.0% | -5.3% | 0.06% |
| 1 Year | -17.8%-17.8% | 15.8%15.6% | 9.7%7.3% |
| 3 Year | 35.4%35.4% | 57.1%56.6% | 46.3%36.9% |
| 5 Year | 17.8%11.2% | 49.8%48.7% | 64.5%46.5% |
Price Volatility Vs. Market
How volatile is NextGen Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall St
Our Take On NextGen Healthcare, Inc.'s (NASDAQ:NXGN) CEO Salary2 weeks ago | Simply Wall St
Is Now The Time To Look At Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?3 weeks ago | Simply Wall St
NextGen Healthcare, Inc. (NASDAQ:NXGN) Delivered A Weaker ROE Than Its IndustryValuation
Is NextGen Healthcare undervalued compared to its fair value and its price relative to the market?
23.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: NXGN ($16.26) is trading below our estimate of fair value ($21.17)
Significantly Undervalued: NXGN is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: NXGN is good value based on its PE Ratio (45.5x) compared to the Healthcare Services industry average (55x).
PE vs Market: NXGN is poor value based on its PE Ratio (45.5x) compared to the US market (17.7x).
Price to Earnings Growth Ratio
Low PEG Ratio: NXGN is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: NXGN is good value based on its PB Ratio (2.8x) compared to the US Healthcare Services industry average (3.7x).
Next Steps
Future Growth
How is NextGen Healthcare forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
24.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NXGN's forecast earnings growth (24% per year) is above the savings rate (2.7%).
Earnings vs Market: NXGN's earnings (24% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NXGN's revenue (6.7% per year) is forecast to grow slower than the US market (7.3% per year).
High Growth Revenue: NXGN's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: NXGN's Return on Equity is forecast to be low in 3 years time (11.3%).
Next Steps
Past Performance
How has NextGen Healthcare performed over the past 5 years?
-4.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: NXGN's earnings have declined by -4.5% per year over the past 5 years.
Accelerating Growth: NXGN's earnings growth over the past year (1870.1%) exceeds its 5-year average (-4.5% per year).
Earnings vs Industry: NXGN earnings growth over the past year (1870.1%) exceeded the Healthcare Services industry 3.3%.
Return on Equity
High ROE: NXGN's Return on Equity (6.1%) is considered low.
Return on Assets
ROA vs Industry: NXGN's Return on Assets is below or equal to the Healthcare Services industry average last year.
Return on Capital Employed
ROCE Improving: NXGN's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is NextGen Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: NXGN's short term assets ($155.5M) exceeds its short term liabilities ($128.3M)
Long Term Liabilities: NXGN's short term assets (155.5M) exceeds its long term liabilities (58.2M)
Debt to Equity History and Analysis
Debt Level: NXGN's debt to equity ratio (1.6%) is considered satisfactory
Reducing Debt: Insufficient data to determine if NXGN's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: NXGN's debt is well covered by operating cash flow (1074.3%).
Interest Coverage: NXGN's interest payments on its debt are well covered by EBIT (10.6x coverage).
Balance Sheet
Inventory Level: NXGN has a low level of unsold assets or inventory.
Debt Coverage by Assets: NXGN's debt is covered by short term assets (assets are 25.919330x debt).
Next Steps
Dividend
What is NextGen Healthcare's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate NXGN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate NXGN's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if NXGN's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NXGN's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: NXGN is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NXGN's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of NextGen Healthcare's salary, the management and board of directors tenure and is there insider trading?
3.4yrs
Average management tenure
CEO
Rusty Frantz (52yo)
4.3yrs
Tenure
US$6,833,956
Compensation
Mr. John R. Frantz, also known as Rusty, serves as President and Chief Executive Officer of NextGen Healthcare information Systems, LLC. Mr. Frantz has been the President and Chief Executive Officer of Nex ...
CEO Compensation Analysis
Compensation vs. Market: Rusty's total compensation ($USD6.83M) is about average for companies of similar size in the US market ($USD2.67M).
Compensation vs Earnings: Rusty's compensation has increased by more than 20% in the past year.
Management Age and Tenure
3.4yrs
Average Tenure
56yo
Average Age
Experienced Management: NXGN's management team is considered experienced (3.4 years average tenure).
Board Age and Tenure
6.8yrs
Average Tenure
56yo
Average Age
Experienced Board: NXGN's board of directors are considered experienced (6.8 years average tenure).
Insider Trading
Insider Buying: NXGN insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Shares | 865,623 |
| Max Price | US$16.66 |
| Entity | Individual |
| Role | Member of the Board of Directors Chairman Emeritus |
| Shares | 21,900 |
| Max Price | US$19.07 |
| Entity | Individual |
| Role | Member of the Board of Directors Chairman Emeritus |
| Shares | 4,018 |
| Max Price | US$19.06 |
| Entity | Individual |
| Role | Member of the Board of Directors Chairman Emeritus |
| Shares | 22,568 |
| Max Price | US$19.10 |
| Entity | Individual |
| Role | Member of the Board of Directors Chairman Emeritus |
| Shares | 1,113 |
| Max Price | US$19.03 |
| Entity | Individual |
| Role | Member of the Board of Directors Chairman Emeritus |
| Shares | 32,301 |
| Max Price | US$19.40 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 13,873 |
| Max Price | US$19.29 |
Ownership Breakdown
Management Team
Jeff Linton (56yo)
Executive VP
- Tenure: 1.8yrs
- Compensation: US$1.30m
Jamie Arnold (63yo)
Executive VP
- Tenure: 3.6yrs
- Compensation: US$2.37m
John Beck
Chief Solutions Officer & Executive VP
- Tenure: 3.2yrs
Donna Greene
Senior Vice President of Human Resources
- Tenure: 0yrs
Rusty Frantz (52yo)
President
- Tenure: 4.3yrs
- Compensation: US$6.83m
Betty Rabinowitz
Chief Medical Officer
- Tenure: 1.5yrs
David Metcalfe (56yo)
Executive VP & Chief Technology Officer
- Tenure: 3.7yrs
- Compensation: US$1.92m
Asher Dewhurst
Investor Relations
- Tenure: 0yrs
Board Members
Lance Rosenzweig (56yo)
Independent Director
- Tenure: 7.4yrs
- Compensation: US$247.02k
Jeff Margolis (56yo)
Independent Chairman
- Tenure: 3.9yrs
- Compensation: US$315.02k
Sheldon Razin (81yo)
Chairman Emeritus
- Tenure: 45.8yrs
- Compensation: US$315.02k
Morris Panner (56yo)
Independent Director
- Tenure: 6.8yrs
- Compensation: US$261.02k
Julie Klapstein (64yo)
Independent Director
- Tenure: 2.2yrs
- Compensation: US$265.02k
Jim Malone (70yo)
Independent Director
- Tenure: 6.8yrs
- Compensation: US$277.02k
George Bristol (70yo)
Independent Director
- Tenure: 11.1yrs
- Compensation: US$281.02k
Craig Barbarosh (51yo)
Independent Vice Chairman
- Tenure: 3.9yrs
- Compensation: US$369.02k
Rusty Frantz (52yo)
President
- Tenure: 4.3yrs
- Compensation: US$6.83m
Company Information
NextGen Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: NextGen Healthcare, Inc.
- Ticker: NXGN
- Exchange: NasdaqGS
- Founded: 1974
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$1.063b
- Shares outstanding: 65.38m
- Website: https://www.nextgen.com
Number of Employees
Location
- NextGen Healthcare, Inc.
- 18111 Von Karman Avenue
- Suite 800
- Irvine
- California
- 92612
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| NXGN | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Dec 1982 |
| QY1 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Dec 1982 |
Biography
NextGen Healthcare, Inc. provides ambulatory-focused healthcare software and services solutions in the United States. The company’s principal products include NextGen Enterprise electronic health record (E ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/17 23:39 |
| End of Day Share Price | 2019/10/17 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.